Nasopharyngeal swab for rt pcr for respiratory panel Both viral bacterial fungal What does this mean and specimen for those and test names
Reading File
Finding Sources
Searching the Web
nasopharyngeal swab RT-PCR respiratory panel viral bacterial fungal pathogens list specimen 2025
Here is a detailed breakdown of everything you asked about:
Nasopharyngeal (NP) Swab RT-PCR Respiratory Panel
What Does This Mean?
A Respiratory Panel (RP) by RT-PCR is a multiplex molecular test that simultaneously detects nucleic acids (DNA or RNA) of multiple respiratory pathogens from a single specimen. "RT-PCR" stands for Reverse Transcription Polymerase Chain Reaction - necessary for RNA viruses (which must be converted to DNA before amplification).
- It detects each pathogen qualitatively - reported as Detected / Not Detected (positive or negative)
- Results come in approximately 1-4 hours depending on platform
- It does NOT indicate severity, bacterial load, or antibiotic susceptibility
- Modern panels can detect 17-22+ pathogens in one run
Specimen Types
| Specimen | Notes |
|---|---|
| Nasopharyngeal (NP) swab | Gold standard - deep swab reaching posterior nasopharynx; best for most respiratory viruses and atypical bacteria |
| Oropharyngeal (OP) swab | Used for some panels; less sensitive for some pathogens |
| Bronchoalveolar lavage (BAL) | For lower respiratory / immunocompromised patients; extended fungal panels |
| Sputum | For some bacterial and fungal extended panels |
| Nasopharyngeal wash/aspirate | Higher yield in young children; more sensitive than swabs in infants |
| Mid-turbinate swab | Acceptable alternative in some protocols |
| Anterior nasal swab | Used for self-collection (e.g., COVID rapid PCR) |
For the standard RP panel, the NP swab in viral transport medium (VTM) is the primary specimen.
What Pathogens Are Detected?
VIRUSES (Most comprehensive coverage in standard panels)
| Pathogen | Notes |
|---|---|
| Influenza A (including subtypes H1N1, H3N2) | Seasonal flu |
| Influenza B | Seasonal flu |
| Influenza C | Some extended panels |
| Respiratory Syncytial Virus (RSV) A/B | Major cause in infants and elderly |
| SARS-CoV-2 | COVID-19 |
| Human Metapneumovirus (hMPV) | RSV-like illness |
| Parainfluenza Virus 1, 2, 3, 4 | Croup, bronchiolitis |
| Human Adenovirus | Pharyngitis, pneumonia |
| Human Rhinovirus / Enterovirus | Common cold, bronchiolitis |
| Coronavirus 229E, OC43, NL63, HKU1 | Common cold coronaviruses |
| Human Bocavirus | Children with LRTI |
| Human Parechovirus | Neonates / young children |
BACTERIA (Atypical and fastidious - not detected by standard culture easily)
| Pathogen | Notes |
|---|---|
| Mycoplasma pneumoniae | "Walking pneumonia" in school-age children and young adults |
| Chlamydia pneumoniae | Atypical pneumonia |
| Bordetella pertussis | Whooping cough |
| Bordetella parapertussis | Pertussis-like illness |
| Staphylococcus aureus | Extended panels |
| Streptococcus pneumoniae | Extended panels |
| Klebsiella pneumoniae | Extended panels |
| Haemophilus influenzae | Extended panels |
| Legionella pneumophila | Legionnaire's disease |
| Moraxella catarrhalis | Upper RTI in children |
| Acinetobacter baumannii | Extended / hospital panels |
| Pseudomonas aeruginosa | Extended panels; CF patients |
| Streptococcus pyogenes | Group A Strep |
Note: Standard FDA-cleared panels (BioFire, QIAstat) typically include Mycoplasma, Chlamydia, Bordetella as bacterial targets. The larger extended/custom panels add the others above.
FUNGI (Limited coverage; mostly extended or specialized panels)
| Pathogen | Notes |
|---|---|
| Pneumocystis jirovecii (PJP) | Most commonly included fungal target; critical in immunocompromised |
| Aspergillus species | Extended panels; BAL preferred specimen |
| Candida species | Extended panels |
| Histoplasma capsulatum | Targeted testing / extended metagenomics |
| Cryptococcus neoformans | Extended / metagenomics |
| Coccidioides immitis | Extended / targeted |
Fungal targets are not routinely included in most standard NP swab RT-PCR panels. When fungal coverage is needed (especially in immunocompromised patients), BAL is the preferred specimen, and tests like Aspergillus galactomannan, beta-D-glucan, or metagenomic NGS (mNGS) are used.
Named Commercial Tests / Panels
| Test Name | Manufacturer | Targets | Specimen |
|---|---|---|---|
| BioFire FilmArray Respiratory Panel 2.1 (RP2.1) | BioFire Diagnostics | 22 targets (viral + bacterial) including SARS-CoV-2 | NP swab |
| BioFire FilmArray Pneumonia Panel (BCID) | BioFire Diagnostics | 33 targets including fungi and resistance genes | BAL, sputum |
| QIAstat-Dx Respiratory SARS-CoV-2 Panel | QIAGEN | 22 targets | NP swab |
| ePlex Respiratory Pathogen Panel 2 (RP2) | GenMark Dx | 21 targets | NP swab |
| Cobas Liat Flu/RSV A+B & COVID-19 | Roche | 4-target combo panel | NP swab |
| Xpert Xpress SARS-CoV-2/Flu/RSV | Cepheid | 4 targets | NP swab |
| Luminex NxTAG Respiratory Pathogen Panel | Luminex | 21 targets | NP swab |
| Mayo Clinic Respiratory Panel (RP) | Mayo Clinic Labs | 22 targets including SARS-CoV-2 | NP swab |
| MedGenome Respiratory Pathogen Multiplex RT-PCR | MedGenome | 31 targets (viral + bacterial + Pneumocystis) | NP swab / BAL |
| Metagenomic NGS (mNGS) | Various | Comprehensive - bacteria, viruses, fungi, parasites | BAL preferred |
Key Points to Remember
- Standard NP swab RP panels cover mainly viruses + atypical bacteria (Mycoplasma, Chlamydia, Bordetella)
- Fungal coverage on NP swab is very limited - mostly just Pneumocystis jirovecii on extended panels
- For comprehensive fungal detection, BAL + specialized assays (galactomannan, beta-D-glucan, culture, mNGS) are needed
- These are qualitative tests - positive means pathogen nucleic acid detected, does NOT mean causative agent
- A standard respiratory culture is still needed for susceptibility testing (antibiotic sensitivity)
- Most useful in early illness, immunocompromised patients, and hospitalized patients to guide isolation and treatment rapidly
This is a shared conversation. Sign in to Orris to start your own chat.